Tag archive for ‘Lilian Montero’
Shiri Habib-Valdhorn On Tuesday, April 28th, 2015

“Even at $100 per share Teva’s Mylan bid worthwhile”

  “Mylan Laboratories is a good acquisition target for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), and in my opinion, Teva’s shareholders will welcome it, but it also More...

Wordpress site Developed by Fixing WordPress Problems